1. Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma
   Rita C. Akumuo et al, 2024, Journal of Gastrointestinal Surgery CrossRef
2. Nanotechnology-empowered lung cancer therapy: From EMT role in cancer metastasis to application of nanoengineered structures for modulating growth and metastasis
   Hiba Muwafaq Saleem et al, 2023, Environmental Research CrossRef
3. What are the changes in the hotspots and frontiers of microRNAs in hepatocellular carcinoma over the past decade?
   Lu Zhang et al, 2024, World Journal of Clinical Oncology CrossRef
4. OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression
   Naixin Liu et al, 2023, Current Neuropharmacology CrossRef
5. Chemoresistance and the tumor microenvironment: the critical role of cell–cell communication
   Bartosz Wilczyński et al, 2024, Cell Communication and Signaling CrossRef
6. miRNA-21, an oncomiR that regulates cell proliferation, migration, invasion and therapy response in lung cancer
   Roberta Queiroz da Silvia Lima et al, 2024, Pathology - Research and Practice CrossRef
7. Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance
   Daria Molodtsova et al, 2023, International Journal of Molecular Sciences CrossRef
8. Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential
   Ryan N. Fuller et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
9. Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
   Hongshuang Dai et al, 2023, Annals of Medicine CrossRef